Back to Journals » Vascular Health and Risk Management » Volume 16

Case Report on a Patient with Steinert Disease Complicated by COVID-19

Authors Chalela R, Caguana O, Zuccarino F, Khilzi K, Rodríguez-Chiaradía DA

Received 6 July 2020

Accepted for publication 29 September 2020

Published 20 November 2020 Volume 2020:16 Pages 463—466

DOI https://doi.org/10.2147/VHRM.S266659

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 6

Editor who approved publication: Professor Magnus Bäck


Roberto Chalela, 1– 4 Oswaldo Caguana, 1, 2 Flavio Zuccarino, 5 Karys Khilzi, 1, 2 Diego A Rodríguez-Chiaradía 1– 4

1Respiratory Medicine Department, Hospital del Mar, Barcelona, Spain; 2Institut Hospital del Mar d’Investigacions Mèdiques (IMIM), Barcelona, Spain; 3Universitat Pompeu Fabra, Barcelona, Spain; 4Centro de Investigación en Red de Enfermedades Respiratorias(CIBERES), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; 5Department of Radiology, Hospital del Mar, Barcelona, Spain

Correspondence: Diego A Rodríguez-Chiaradía
Respiratory Medicine Department, Hospital del Mar, Passeig Maritim, 25, Barcelona, 08003, Spain
Tel +34 932483548
Email DARodriguez@parcdesalutmar.cat

Abstract: SARS-CoV-2 infection is predominantly a respiratory disease with a diverse clinical spectrum. Pulmonary thromboembolic complications during COVID-19 pneumonia may be associated with a high mortality rate and post-mortem findings confirm the presence of platelet-fibrin thrombi in arterial vessels of patients together with lung tissue alterations. We present a patient transferred to the emergency department due to a syncope with no other associated symptoms, who was diagnosed with an acute pulmonary embolism (PE) concomitant with SARS-CoV-2 infection without lung infiltrates. Presenting with a PE as the only manifestation of this infection, reinforces our conception of COVID-19 as a heterogeneous disease of which we still know very little. We believe that while the virus is still circulating in our environment, we need to consider ruling out COVID-19 in all thrombotic events, even if the patients have no other risk factors.

Keywords: COVID-19, SARS-CoV-2, pulmonary embolism, syncope, pandemic

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]